These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 23891860)

  • 1. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Br J Ophthalmol; 2011 Aug; 95(8):1151-6. PubMed ID: 21273213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2345-53. PubMed ID: 23760670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):885-94. PubMed ID: 25663437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells.
    Deissler HL; Rehak M; Busch C; Wolf A
    Exp Eye Res; 2022 Mar; 216():108945. PubMed ID: 35038456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences.
    Deissler HL; Deissler H; Lang GE
    Br J Ophthalmol; 2012 Jul; 96(7):1023-8. PubMed ID: 22539748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):535-42. PubMed ID: 19643968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport and fate of aflibercept in VEGF-A
    Deissler HL; Sommer K; Lang GK; Lang GE
    Exp Eye Res; 2020 Sep; 198():108156. PubMed ID: 32712182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
    Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
    Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165.
    Deissler HL; Lang GK; Lang GE
    Cell Physiol Biochem; 2017; 42(4):1493-1513. PubMed ID: 28719888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
    Deissler H; Deissler H; Lang S; Lang GE
    Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions.
    Peng S; Adelman RA; Rizzolo LJ
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3216-25. PubMed ID: 20042644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.
    Miyamoto N; de Kozak Y; Jeanny JC; Glotin A; Mascarelli F; Massin P; BenEzra D; Behar-Cohen F
    Diabetologia; 2007 Feb; 50(2):461-70. PubMed ID: 17187248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
    Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
    Wisniewska-Kruk J; Hoeben KA; Vogels IM; Gaillard PJ; Van Noorden CJ; Schlingemann RO; Klaassen I
    Exp Eye Res; 2012 Mar; 96(1):181-90. PubMed ID: 22200486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.
    Suarez S; McCollum GW; Bretz CA; Yang R; Capozzi ME; Penn JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8232-40. PubMed ID: 25406289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of VEGF165 and the VEGF aptamer pegaptanib (Macugen) on the protein composition of tight junctions in microvascular endothelial cells of the retina].
    Deissler HL; Lang GE
    Klin Monbl Augenheilkd; 2008 Oct; 225(10):863-7. PubMed ID: 18951306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of binding characteristics and in vitro activities of three inhibitors of vascular endothelial growth factor A.
    Yang J; Wang X; Fuh G; Yu L; Wakshull E; Khosraviani M; Day ES; Demeule B; Liu J; Shire SJ; Ferrara N; Yadav S
    Mol Pharm; 2014 Oct; 11(10):3421-30. PubMed ID: 25162961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.